Health and Beauty

J&J agrees to cease opioid gross sales in a $ 230 million settlement with New York

New York State Attorney General Letitia James speaks during a press conference to announce criminal justice reform on May 21, 2021 in New York City, United States.

Brendan McDermid | Reuters

New York attorney general Letitia James announced on Saturday that Johnson & Johnson agreed to stop opioid sales nationwide in a $ 230 million settlement with New York State.

As part of the settlement, the company will settle opioid-related claims and spread payments over nine years. It could also pay $ 30 million more in the first year if the state executive board signs a new law creating an opioid settlement fund, according to the press release from James’ office.

“The opioid epidemic has wreaked havoc in countless communities in New York state and the rest of the nation, and millions of people are still addicted to dangerous and deadly opioids,” James said in a statement.

“Johnson & Johnson helped start that fire, but today they are committed to leaving the opioid business – not just in New York but across the country,” she said.

This is the latest news. Please check again for updates.

Leave your vote

0 points
Upvote Downvote

Related Articles

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.